ComplianceOnline

Register

Toll Free: +1-888-717-2436

CART 0

Your Shopping Cart

Contains 0 items
Total: $0.00
View Shopping Cart
Cart Image



Biotech/Biosimilar Products: Current and Emerging Analytical CMC Expectations

By:
Nadine M Ritter, Senior CMC Consultant at Biologics Consulting Group, Inc
Coming soon.. Please contact customer care for new schedule

Course Description:

In the development and commercialization of biopharmaceutical products, historically most of the R&D and GMP attention has been focused on the manufacturing process and production facility. However, there has always been a vital role for the ‘other half’ of the equation: analytical testing and laboratory operations.

The global emergence of biosimilar products – where significant attention is given to analytical characterization and comparability – has turned a brighter spotlight on the analytics. It is expected that rationale for the design and execution of analytical studies, the selection of and validation of appropriate method technologies, the assessment of drug substance and drug product stability, and the establishment of meaningful, supportable specifications will be justified in regulatory dossiers.

This two day interactive course on CMC requirements for biopharmaceutical products will focus on the types of analytical CMC studies that are critical to the successful review and approval of product IND/IMPD and BLA/MAA filings. It will also discuss the vital role of laboratory quality systems in assuring the reliability and integrity of the data generated to demonstrate product comparability, quality and stability.

Complementary USB Drive for first 20 Registrations: Register Now and get a complementary USB drive containing over 200 global guidance documents and industry white papers applicable to the information discussed. Additionally attendees will be given links to many places where they can continuously update their knowledge of the topics covered.





Learning Objectives:

Upon completing this course on analytical CMC regulations, participants will:

  • Recognize the system of worldwide regulatory guidance applicable to biotech and biosimilar product CMC requirements
  • Understand why requirements for biotech products are so different from those of chemical products
  • Find exactly ‘where it is written’ for current and emerging CMC expectations for biotech/biosimilar products, and get copies of those regulatory documents
  • See how to implement a staged approach to establishing specifications for release and stability testing
  • Learn the current analytical technologies used for establishing biotech/biosimilar product characteristics and assessing comparability
  • Select the appropriate methods for release and stability testing
  • Design suitable qualification and validation exercises for method intended uses
  • Establish stage-appropriate ICH stability protocols
  • Learn the tiered approach for managing product reference standards
  • Recognize how much R&D data are exposed to regulatory scrutiny
  • See the new regulatory guidance on quality agreements with contract testing labs


Who will Benefit:

This course is designed for people tasked with designing, conducting, auditing, or managing key CMC studies; writing dossiers or responding to communications for submission to regulatory authorities; preparing for or conducting inspections of analytical labs for biotech or biosimilar products. Following personnel will benefit from the course:

  • CMC study directors
  • Method development specialists
  • Process development specialists
  • R&D scientists
  • QC technicians
  • QC laboratory managers
  • Stability program managers
  • QA professionals
  • CRO personnel
  • Technical writers
  • Laboratory inspectors
  • Regulatory professionals
  • Compliance professionals





Course Outline:

Day One (8:30 AM – 4:30 PM) Day Two (8:30 AM – 4:30 PM)

Registration Process: 8:30 AM – 9:00 AM

Session Start Time: 9:00 AM

  1. Current and Emerging Biotechnology/Biosimilars CMC Regulatory Requirements
    1. What sets of world-wide regulations detail CMC analytical study requirements for biotechnology/biosimilar products?
    2. What are the 10 (or 11 if biosimilar) non-negotiable CMC characterization, comparability, release specification and stability data packages required for a biotechnology-based product?
    3. Where is it written that these are the required CMC studies and data to be presented in each regulatory dossier for biotechnology/biosimilar products?
    4. What are some of the current CMC ‘hot buttons’ for biotechnology analytical and stability studies that are of increasing regulatory concern for chronic deficiencies in product dossiers?
    5. What are the current analytical questions for global development of biosimilar products?
    6. How the required CMC analytical and stability studies should be staged during the product development lifecycle?
    7. Which of these elements have the most critical project planning considerations based on their time and material requirements for biotechnology/biosimilar products, and why?
  2. Managing Stage-Specific Specifications for Biotech/Biosimilar Products
    1. Why do biotechnology products have different specification requirements versus traditional chemical products for comparability, product quality and consistency, and shelf life determination?
    2. What four main elements are critical for establishing reliable, meaningful product specifications for biotech and biosimilar products?
    3. What are the specification considerations for product-related heterogeneity in biotechnology products?
    4. What is the basis for specifications on product and process related impurities?
    5. How much detail is required on impurities and degradants at each phase of product development?
    6. What are the key points to include in the Justification of Specifications for drug substance and drug product?
  3. Analytical Test Method Selection and Specifications for Biotechnology/Biosimilar Products
    1. How do regulators and inspectors categorize analytical test methods?
    2. What are the commonly used and currently expected analytical methods for various types of biotechnology products (eg Mabs, vaccines, GT vectors, ADCs, etc…)?
    3. Why do biotech products require orthogonal methods for physiochemical characteristics as well as functional potency assays?
    4. What is the difference between methods used for characterization and comparability studies vs release and stability testing?

  1. Biotech/Biosimilar Analytical Methods: Development, Qualification, Validation, Tech Transfer and Bridging
    1. Which analytical test methods have to be validated, and by when?
    2. What is the difference between method validation and method ‘qualification’?
    3. How can you tell if method qualification or validation studies have been designed correctly for each analytical technology and intended use?
    4. What should you do to tech-transfer analytical methods from one lab to another?
    5. What should you do to make changes in release and stability analytical methods over time?
    6. What are the current expectations for generating and maintaining method lifecycle document packages?
    7. How can one separate tracking of method performance from product performance to monitor each method’s state of control?
  2. Design and Execution of Analytical Comparability Studies for Biotechnology and Biosimilar Products
    1. What are critical technical aspects of assessing biotechnology product comparability?
    2. How do comparability studies performed for developmental continuity differ from demonstration of analytical biosimilarity?
    3. What are key elements of conducting a biotechnology product comparability or analytical biosimilarity study?
    4. How do you strategically select among the collection of analytical methods for comparability/biosimilarity vs release/stability testing?
  3. Reference Standards and Materials for Biotechnology/Biosimilar Products
    1. What are some of the types and uses of biotechnology reference standards and materials?
    2. How do they differ from small molecule reference standards?
    3. What is the ‘tiered approach’ to establishing a master reference standard and qualifying working reference standards?
    4. How is biotechnology product reference standard stability monitored?
    5. How do you bridge new lots of reference standards and materials?
  4. Biotech/Biosimilar Product Stability Studies and Stability-Indicating Method Validation
    1. What are the requirements for biotech product stability studies during development and post approval?
    2. What is required to qualify vs validate methods that are claimed to be stability-indicating?
    3. Why can’t shelf life dates be extrapolated from accelerated stability data for biotech/biosimilar products?
    4. What are the critical elements to include in sound stability protocols for drug substance and drug product?
    5. What are the current expectations for extractable/leachable studies for biotech/biosimilar product container/closure interactions?
    6. What are the emerging expectations for subvisible and visible particle determination for biotech/biosimilar products throughout shelf life?
  5. Lab Quality Practices from R&D to GxP
    1. How much regulatory analytical data comes from R&D labs?
    2. What are the emerging expectations for lab quality practices for R&D labs, and how do they align with the principles of ICHQ10?
    3. What are the 6 key regulatory/compliance information packages expected from biotech/biosimilar analytical groups from R&D through GMP?
    4. What are the key similarities and differences among the current compliance expectations for GxP testing labs?
    5. What are the significant new expectations for quality agreements between contract testing labs and sponsors?
  6. Continuing Education Links Associated with Biotech CMC Analytical, Quality and Regulatory Issues





Meet Your Instructor

Nadine M. Ritter
Senior CMC Consultant at Biologics Consulting Group, Inc

Nadine M. Ritter,Ph.D., senior consultant for Biologics Consulting Group, Inc., is a protein chemist with expertise in the chemistry, manufacturing and control (CMC) of biotechnology products. She is past Director of Analytical Services Division at major contract testing organization performing R&D, GLP and GMP analytics studies. For over 15 yrs, she has contributed data to numerous US and international regulatory IND/IMP and BLA/NDA/MAA filings.

She also has considerable experience conducting audits of sponsor and contract laboratories worldwide. She is a member of several professional analytical organizations, and is frequently invited as a speaker and writer on analytical and stability issues.





Register Online


Get the Invitation
Pre-Register yourself and get the official Invite when venue and dates are announced for this seminar.
Call here to register +1-888-717-2436 or email at customercare@complianceonline.com


Register by P.O. / Check


Yes, I want to attend "Biotech/Biosimilar Products: Current and Emerging Analytical CMC Expectations".

If you are paying by check:

Checks should be payable to MetricStream Inc. (our parent company) and mailed to:
2479 East Bayshore Road
Suite 200
Palo Alto, CA 94303
USA

Group Registrations

Significant tuition discounts are available for teams of two or more from the same company. You must register at the same time and provide a single payment to take advantage of the discount.

2 Attendees - Get 10% off
3 to 6 Attendees - Get 20% off
7 to 10 Attendees - Get 25% off
10+ Attendees - Get 30% off

Register by Wire Transfer




Terms & Conditions to Register for the Seminar/Conference/Event

Your registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-717-2436 or email us @ editor@complianceonline.com

Payment:
Payment is required 2 days before the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. (our parent company).

Cancellations and substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund — less a $200 administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days before the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($200) will be transferred to any future ComplianceOnline event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite, payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available, we will send the material after the conference is over.

In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Attendance confirmation and documents to carry to the seminar venue:
After we receive the payment from the registered attendee, an electronic event pass will be sent to the email address associated with the registrant 5 working days before the seminar date. Please bring the pass to the venue of the event.

Conference photograph / video:
By registering and attending ComplianceOnline conference, you agree to have your photographs or videos taken at the conference venue and you do not have any objections to ComplianceOnline using these photos and videos for marketing, archiving or any other conference related activities. You agree to release ComplianceOnline from any kind of claims arising out of copyright or privacy violations.

Media Partners

Sponsors



Media Partner Benefits
  • Logo and company data on the event website.
  • Logo on the conference material distributed during the conference.
  • Media Partner’s brochure distributed along with conference material.
  • Logo on all the mailings before and after the event.
  • 10% discount to media partner's subscribers.


Media Partner to do
  • Banner (min 728x90 or 468x60) on the Media Partner website.
  • Insertion of the event in the event calendar, both printed and/or online.
  • Announcement article of the conference on the Magazine and/or Website.
  • Dedicated email blast to all subscribers of Media Partner.
  • Article on the Magazine and/or Website after the conference.







Local Attractions

Located in the heart of Cupertino, Bowlmor Lanes Cupertino is a hip attraction where crowds can get more than the average night out. Bowlmor Lanes Cupertino features 32 lanes of glow-in-the-dark bowling, video screens on the walls, a top-notch sound system, a full sports bar and a billiards room. There is also a restaurant that serves up tasty fare lane-side so hungry guests don't have to abandon their game.




The Campbell Historical Museum and Ainsley House may have been procured from the city of San Jose by Campbell, but this adorable English Tudor is still the perfect visiting stop for anyone in the county looking for a plush little getaway from modern times. The iconic English Tudor is elegantly restored and filled with many of the Ainsley's original furnishings (the couple built the house in 1925 to resemble the cottages of their native Britain). Bring a folding chair and a picnic basket for a series of free outdoor concerts every Thursday evening. Just because the setting is classic doesn't mean you can't engage in some modern fun.




Just outside of the San Jose city limits, Campo di Bocce is a unique venue that remains a favorite San Jose attraction. With a full restaurant offering delicious Italian cuisine, a bar doling out everything from sodas to cocktails, and several bocce courts where everyone from family to friends to co-workers can try their hand at bocce ball and engage in light competition or just a fun and casual game.




Serving the needs of children, families, and schools as a center for learning and discovery, this museum in downtown San Jose features interactive hands-on exhibits, programs, puzzles, games, classes and much more.




Imagine driving a luxury or exotic car without the pressures and expenses of ownership and maintenance. Club Sportiva is the most established luxury car time-share in the nation, with memberships that put drivers behind the wheel of the world's finest cars a few days each month. Members also enjoy benefits like social events, dinners, road rallies and other exclusive VIP services. Limited-production Ferraris and Lamborghinis and electric Tesla Roadsters are available now.




Although San Jose is home to many attractions, few boast the natural beauty and scenic views of Deep Cliff golf club. San Jose visitors and locals alike enjoy playing this 18-hole par 60 course. Deep Cliff also offers golf lessons, a driving range, cafe and space for corporate events and private parties. This San Jose attraction is a welcomed escape from busy city life, allowing golf enthusiasts and beginners a lush place to hit the links.




Santa Clara's K1 Speed brings eco-friendly and european-influenced go kart racing to the greater Bay Area, with zero-emission electric karts that maintain the same tire marks without the carbon footprint. K1 Speed is the nation's largest indoor go kart racing company, and Santa Clara is now housing its newest location. The newly-opened track features the high standard specifications that K1 Speed is known for, including a professionally designed 50,000 sp. ft. racetrack, with high performance electric karts that reach speeds of 45 mph. And when taking a break from the track, individuals can relax in the spacious lobby which features the Pit Cafe, displayed memorabilia and video games. And for the more competitive racer, K1 Speed ties every racer nationwide together by comparing their track competition time through the K1 Speed center.




Thrill seekers wanted! LeMans Karting is the San Francisco Bay Area's fastest indoor go kart racing facility. With 9-horsepower go karts that reach speeds of 40-mph and a twenty-foot wide race track, everyone will enjoy the fast-paced, heart-pounding racing action. The private event room overlooks the entire race track and is perfect for meetings and parties alike. For extreme go kart racing, LeMans Karting offers racing leagues that allow novice and pro racers to test their skills in endurance and competition go kart racing. LeMans Karting is open seven days a week and reservations are required.




Whether looking up into the heavens or down into the valley below, the views from the high point of Lick Observatory can't be beat on a clear day or night.




Chock-full of unique hands-on exhibits, this cosmopolitan museum in the heart of downtown San Jose singularly focuses on how technology functions and is changing every aspect of the way we work, live, play and learn.






Follow us :
We need below information to serve you better